StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2018, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 01 Jun 2017 16:16:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form 8-K Propanc Biopharma, Inc. For: May 26 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Biopharma%2C+Inc.+++For%3A+May+26/12970404.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Biopharma%2C+Inc.+++For%3A+May+26/12970404.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Biopharma%2C+Inc.+++For%3A+May+26/12970404.html Thu, 01 Jun 2017 16:16:00 -0500 PPCH Propanc Successfully Completes 28-Day Repeat-Dose Toxicity Study for PRP http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html Thu, 27 Apr 2017 08:51:00 -0500 A.39807895 PPCH PPCHD Propanc Successfully Completes 28-Day Repeat-Dose Toxicity Study for PRP http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html Thu, 27 Apr 2017 08:51:00 -0500 A.39807895 PPCH PPCHD Propanc Successfully Completes 28-Day Repeat-Dose Toxicity Study for PRP http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+Successfully+Completes+28-Day+Repeat-Dose+Toxicity+Study+for+PRP/12821540.html Thu, 27 Apr 2017 08:51:00 -0500 A.39807895 PPCH PPCHD Propanc CEO James Nathanielsz's FDA Policy Proposals Published in Pharma Trade Media http://www.streetinsider.com/Press+Releases/Propanc+CEO+James+Nathanielsz%26apos%3Bs+FDA+Policy+Proposals+Published+in+Pharma+Trade+Media/12796222.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+CEO+James+Nathanielsz%26apos%3Bs+FDA+Policy+Proposals+Published+in+Pharma+Trade+Media/12796222.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+CEO+James+Nathanielsz%26apos%3Bs+FDA+Policy+Proposals+Published+in+Pharma+Trade+Media/12796222.html Thu, 20 Apr 2017 10:07:00 -0500 PPCH PPCHD Propanc CEO James Nathanielsz's FDA Policy Proposals Published in Pharma Trade Media http://www.streetinsider.com/Press+Releases/Propanc+CEO+James+Nathanielsz%26apos%3Bs+FDA+Policy+Proposals+Published+in+Pharma+Trade+Media/12796222.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+CEO+James+Nathanielsz%26apos%3Bs+FDA+Policy+Proposals+Published+in+Pharma+Trade+Media/12796222.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+CEO+James+Nathanielsz%26apos%3Bs+FDA+Policy+Proposals+Published+in+Pharma+Trade+Media/12796222.html Thu, 20 Apr 2017 10:07:00 -0500 PPCH PPCHD Propanc Provides Update on Reverse Stock Split and Upcoming Milestones & Events http://www.streetinsider.com/Press+Releases/Propanc+Provides+Update+on+Reverse+Stock+Split+and+Upcoming+Milestones+%26amp%3B+Events/12775653.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+Provides+Update+on+Reverse+Stock+Split+and+Upcoming+Milestones+%26amp%3B+Events/12775653.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+Provides+Update+on+Reverse+Stock+Split+and+Upcoming+Milestones+%26amp%3B+Events/12775653.html Thu, 13 Apr 2017 08:30:00 -0500 A.12091790 PPCH Propanc Provides Update on Reverse Stock Split and Upcoming Milestones & Events http://www.streetinsider.com/Press+Releases/Propanc+Provides+Update+on+Reverse+Stock+Split+and+Upcoming+Milestones+%26amp%3B+Events/12775653.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+Provides+Update+on+Reverse+Stock+Split+and+Upcoming+Milestones+%26amp%3B+Events/12775653.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+Provides+Update+on+Reverse+Stock+Split+and+Upcoming+Milestones+%26amp%3B+Events/12775653.html Thu, 13 Apr 2017 08:30:00 -0500 A.12091790 PPCH Form 8-K Propanc Health Group For: Apr 04 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Apr+04/12748316.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Apr+04/12748316.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Apr+04/12748316.html Wed, 05 Apr 2017 09:02:00 -0500 PPCH Form 8-K Propanc Health Group For: Mar 31 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Mar+31/12731576.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Mar+31/12731576.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Mar+31/12731576.html Fri, 31 Mar 2017 16:10:00 -0500 PPCH Propanc Authorizes Reverse Stock Split and Corporate Name Change to Propanc Biopharma, Inc. http://www.streetinsider.com/Press+Releases/Propanc+Authorizes+Reverse+Stock+Split+and+Corporate+Name+Change+to+Propanc+Biopharma%2C+Inc./12731455.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+Authorizes+Reverse+Stock+Split+and+Corporate+Name+Change+to+Propanc+Biopharma%2C+Inc./12731455.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+Authorizes+Reverse+Stock+Split+and+Corporate+Name+Change+to+Propanc+Biopharma%2C+Inc./12731455.html Fri, 31 Mar 2017 16:05:00 -0500 PPCH Propanc Receives Patentability Opinion for Method of Treating Cancer Stem Cells http://www.streetinsider.com/Press+Releases/Propanc+Receives+Patentability+Opinion+for+Method+of+Treating+Cancer+Stem+Cells/12712581.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Propanc+Receives+Patentability+Opinion+for+Method+of+Treating+Cancer+Stem+Cells/12712581.html for the full story. http://www.streetinsider.com/Press+Releases/Propanc+Receives+Patentability+Opinion+for+Method+of+Treating+Cancer+Stem+Cells/12712581.html Tue, 28 Mar 2017 08:30:00 -0500 PPCH Form 8-K Propanc Health Group For: Mar 17 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Mar+17/12690575.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Mar+17/12690575.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Propanc+Health+Group++++++For%3A+Mar+17/12690575.html Tue, 21 Mar 2017 09:21:00 -0500 PPCH Form DEF 14C Propanc Health Group For: Mar 15 http://www.streetinsider.com/SEC+Filings/Form++DEF+14C++++Propanc+Health+Group++++++For%3A+Mar+15/12662796.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++DEF+14C++++Propanc+Health+Group++++++For%3A+Mar+15/12662796.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++DEF+14C++++Propanc+Health+Group++++++For%3A+Mar+15/12662796.html Mon, 13 Mar 2017 17:07:00 -0500 PPCH